| Primary |
| Product Used For Unknown Indication |
43.1% |
| Muscle Spasms |
21.6% |
| Pyrexia |
7.8% |
| Oropharyngeal Pain |
3.9% |
| Plasmodium Falciparum Infection |
3.9% |
| Restless Legs Syndrome |
3.9% |
| Drug Use For Unknown Indication |
2.0% |
| Dysphagia |
2.0% |
| Fatigue |
2.0% |
| Haemorrhoid Operation |
2.0% |
| Malaria |
2.0% |
| Overdose |
2.0% |
| Pain |
2.0% |
| Sepsis |
2.0% |
|
| Unevaluable Event |
11.5% |
| Vomiting |
11.5% |
| Thrombocytopenia |
7.7% |
| Thrombocytosis |
7.7% |
| Blood Potassium Decreased |
3.8% |
| Cardiac Disorder |
3.8% |
| Eczema |
3.8% |
| Neutropenia |
3.8% |
| Off Label Use |
3.8% |
| Palpitations |
3.8% |
| Pancreatitis |
3.8% |
| Pneumothorax |
3.8% |
| Psychotic Disorder |
3.8% |
| Purpura |
3.8% |
| Pyrexia |
3.8% |
| Retinal Toxicity |
3.8% |
| Subarachnoid Haemorrhage |
3.8% |
| Systemic Inflammatory Response Syndrome |
3.8% |
| Thrombotic Thrombocytopenic Purpura |
3.8% |
| Torsade De Pointes |
3.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
45.0% |
| Product Used For Unknown Indication |
26.1% |
| Malaria |
3.9% |
| Asthma |
3.6% |
| Hypertension |
3.4% |
| Drug Exposure During Pregnancy |
2.7% |
| Muscle Spasms |
2.1% |
| Plasmodium Falciparum Infection |
2.0% |
| Cerebral Malaria |
1.4% |
| Arthritis |
1.3% |
| Restless Legs Syndrome |
1.3% |
| Antiretroviral Therapy |
1.1% |
| Completed Suicide |
1.1% |
| Infection Parasitic |
1.1% |
| Pneumonia |
1.1% |
| Hiv Infection |
0.9% |
| Convulsion |
0.5% |
| Dialysis |
0.5% |
| Multiple Allergies |
0.5% |
| Rheumatoid Arthritis |
0.5% |
|
| Pancreatic Carcinoma |
16.1% |
| Death |
8.0% |
| Renal Cyst |
8.0% |
| Respiratory Arrest |
8.0% |
| Completed Suicide |
6.9% |
| Renal Failure |
6.9% |
| Drug Hypersensitivity |
5.7% |
| Deafness Permanent |
4.6% |
| Intentional Drug Misuse |
3.4% |
| Intentional Overdose |
3.4% |
| Muscle Spasms |
3.4% |
| No Adverse Event |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Vestibular Disorder |
3.4% |
| Vomiting |
3.4% |
| Abdominal Pain |
2.3% |
| Blood Pressure Decreased |
2.3% |
| Drug Administration Error |
2.3% |
| Drug Toxicity |
2.3% |
| Multiple Drug Overdose |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.6% |
| Drug Use For Unknown Indication |
19.9% |
| Muscle Spasms |
6.0% |
| Rheumatoid Arthritis |
5.0% |
| Hypertension |
4.7% |
| Pain |
4.6% |
| Depression |
3.4% |
| Diabetes Mellitus |
2.5% |
| Hiv Infection |
2.5% |
| Arthritis |
2.3% |
| Nausea |
2.2% |
| Asthma |
1.9% |
| Breast Cancer |
1.8% |
| Osteoporosis |
1.7% |
| Smoking Cessation Therapy |
1.6% |
| Hepatitis C |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Multiple Myeloma |
1.2% |
| Sleep Disorder |
1.2% |
| Back Pain |
1.2% |
|
| Weight Decreased |
14.2% |
| Vomiting |
13.0% |
| Weight Increased |
9.9% |
| Syncope |
5.7% |
| Urinary Tract Infection |
5.7% |
| Vitreous Floaters |
4.8% |
| Suicidal Ideation |
4.2% |
| Renal Impairment |
3.9% |
| Tremor |
3.9% |
| Nausea |
3.6% |
| Pulmonary Embolism |
3.6% |
| Staphylococcal Infection |
3.6% |
| Myocardial Infarction |
3.3% |
| Stillbirth |
3.3% |
| Muscle Spasms |
3.0% |
| Venous Thrombosis |
3.0% |
| Wheezing |
3.0% |
| Paraesthesia |
2.7% |
| Rash |
2.7% |
| Rhabdomyolysis |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
71.8% |
| Convulsion |
12.8% |
| Abdominal Pain Upper |
5.1% |
| Bladder Disorder |
5.1% |
| Plasmodium Falciparum Infection |
5.1% |
|
| Tachypnoea |
50.0% |
| Weight Increased |
25.0% |
| Overdose |
12.5% |
| Plasmodium Falciparum Infection |
12.5% |
|
